Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

46 results

  1. ... W., Rocha, F. G., Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma, Current Problems in SurgeryCurr Probl Surg, 52, 362- ...
  2. ... early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy. European Journal of Clinical Nutrition. 2018; ...
  3. ... P, Capussotti L, Magnino A et al. (2006) Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Annals of ...
  4. ... Sukharamwala P, Thoens J, Szuchmacher M, et al. Advanced age is a risk factor for ... for pancreatic ductal adenocarcinoma. Ann Surg . 2015;2625:868–74. PMID: CN- ...
  5. ... considered a standard treatment option for patients with advanced pancreatic ... ductal adenocarcinoma who had not been treated previously for metastatic ...
  6. ... role of 18F-FDG PET/CT imaging in pancreatic ductal adenocarcinoma patients with diabetes. Pancreatology. 2013 Jul–Aug;13( ... with steady precession dynamic MR imaging in evaluating pancreatic ductal adenocarcinoma. Clin Imaging. 2001;25(1):50–56. Only ...
  7. ... up was cost effective in patients with suspected pancreatic ductal adenocarcinoma (PDAC). The study took a UK NHS and ... up was cost effective in patients with suspected pancreatic ductal adenocarcinoma. The study strongly suggested that the addition of ...
  8. ... 18 and over) with newly diagnosed or recurrent pancreatic ductal adenocarcinoma. Groups that will not be covered Adults (18 ... with confirmed tumours of the pancreas other than pancreatic ductal adenocarcinoma. A.5.2. Settings Settings that will be ...
  9. ... of 24% for the CDKN2A/p16 cohort with pancreatic ductal adenocarcinoma). Very few adverse events as a result of ... of 4-7% for patients with sporadic symptomatic pancreatic ductal adenocarcinoma. Since these figures are higher than what would ...
  10. ... such as insulin. 2 This report focuses on pancreatic ductal adenocarcinoma. Most pancreatic tumors (95%) are exocrine tumors with malignant histologies; ...
first · previous · 1 · 2 · 3 · 4 · 5 · next · last